oxymetazoline hcl

Generic: oxymetazoline hydrochloride

Labeler: padagis israel pharmaceuticals ltd
NDC Directory HUMAN OTC DRUG OTC MONOGRAPH DRUG Inactive Finished

Drug Facts

Product Profile

Brand Name oxymetazoline hcl
Generic Name oxymetazoline hydrochloride
Labeler padagis israel pharmaceuticals ltd
Dosage Form SPRAY
Routes
NASAL
Active Ingredients

oxymetazoline hydrochloride .05 g/100mL

Manufacturer
Padagis Israel Pharmaceuticals Ltd

Identifiers & Regulatory

Product NDC 45802-410
Product ID 45802-410_999f909c-4119-4f4e-9093-6438801b878d
Product Type HUMAN OTC DRUG
Marketing Category OTC MONOGRAPH DRUG
Application Number M012
Marketing Start 2005-12-05
Marketing End 2027-02-28

Pharmacologic Class

Classes
imidazolines [cs] increased sympathetic activity [pe] vasoconstriction [pe] vasoconstrictor [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 45802410
Hyphenated Format 45802-410

Supplemental Identifiers

RxCUI
1000990
UNII
K89MJ0S5VY

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name oxymetazoline hcl (source: ndc)
Generic Name oxymetazoline hydrochloride (source: ndc)
Application Number M012 (source: ndc)
Routes
NASAL
source: ndc

Resolved Composition

Strengths
  • .05 g/100mL
source: ndc
Packaging
  • 1 BOTTLE, SPRAY in 1 CARTON (45802-410-59) / 30 mL in 1 BOTTLE, SPRAY
source: ndc

Packages (1)

45802-410-59 1 BOTTLE, SPRAY in 1 CARTON (45802-410-59) / 30 mL in 1 BOTTLE, SPRAY

Ingredients (1)

oxymetazoline hydrochloride (.05 g/100mL)

Linked Drug Pages (1)

oxymetazoline hcl ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["NASAL"], "spl_id": "999f909c-4119-4f4e-9093-6438801b878d", "openfda": {"unii": ["K89MJ0S5VY"], "rxcui": ["1000990"], "spl_set_id": ["a1103cd8-344b-4a65-8a60-3c7be86d01a6"], "manufacturer_name": ["Padagis Israel Pharmaceuticals Ltd"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE, SPRAY in 1 CARTON (45802-410-59)  / 30 mL in 1 BOTTLE, SPRAY", "package_ndc": "45802-410-59", "marketing_end_date": "20270228", "marketing_start_date": "20051205"}], "brand_name": "oxymetazoline hcl", "product_id": "45802-410_999f909c-4119-4f4e-9093-6438801b878d", "dosage_form": "SPRAY", "pharm_class": ["Imidazolines [CS]", "Increased Sympathetic Activity [PE]", "Vasoconstriction [PE]", "Vasoconstrictor [EPC]"], "product_ndc": "45802-410", "generic_name": "oxymetazoline hydrochloride", "labeler_name": "Padagis Israel Pharmaceuticals Ltd", "product_type": "HUMAN OTC DRUG", "brand_name_base": "oxymetazoline hcl", "active_ingredients": [{"name": "OXYMETAZOLINE HYDROCHLORIDE", "strength": ".05 g/100mL"}], "application_number": "M012", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_end_date": "20270228", "marketing_start_date": "20051205"}